Etoricoxib Use in Breastfeeding Women

Guideline-Based Recommendations

The European League Against Rheumatism (EULAR) recommends that etoricoxib should be avoided in breastfeeding women due to insufficient safety data, and safer NSAID alternatives with established safety profiles should be prescribed instead 1

The Association of Anaesthetists guideline identifies ibuprofen as the preferred choice for breastfeeding women, extensively studied and considered safe with the most reassuring safety data available 2
The Association of Anaesthetists guideline also recommends paracetamol (acetaminophen) as a safe alternative, with infant ingestion via breast milk significantly less than pediatric therapeutic doses 2
The Association of Anaesthetists guideline suggests celecoxib, a COX-2 inhibitor, as a safe alternative to etoricoxib, with very low relative infant dose via milk and explicit compatibility with breastfeeding 2

The Association of Anaesthetists recommends prescribing ibuprofen as first-line for routine pain/inflammation, at the lowest effective dose and shortest duration 2
The Association of Anaesthetists suggests combining NSAIDs with paracetamol to reduce total NSAID exposure for multimodal analgesia 2
The Association of Anaesthetists advises against unnecessarily discontinuing breastfeeding, as the benefits of continued breastfeeding outweigh theoretical minimal drug exposure risks with safe NSAIDs 2

The Association of Anaesthetists recommends extra caution when using NSAIDs in infants under 6 weeks of age, due to immature hepatic and renal function, and observing infants for unusual behavioral changes 2

The Association of Anaesthetists recommends several NSAIDs as safe options during breastfeeding, including Ibuprofen, Diclofenac, Naproxen, Celecoxib, and Ketorolac, due to their established safety profiles and extensive clinical experience 3, 4

Ibuprofen is extensively studied and considered safe during lactation, making it a first-line option for breastfeeding mothers 3, 4
Diclofenac has small amounts detected in breast milk but is considered safe during breastfeeding 3, 4
Naproxen, despite its longer half-life, is widely used after cesarean section with normal breastfeeding 3, 4
Celecoxib has very low relative infant exposure via milk, making it compatible with breastfeeding 3, 4
Ketorolac and Parecoxib have low levels detected in breast milk without demonstrable adverse effects in neonates 3, 4

The first-line option for NSAID selection during breastfeeding is Ibuprofen, due to its extensive study and established safety during lactation 3, 4
Second-line options include Diclofenac and Naproxen, which are considered safe despite small amounts in milk and longer half-life, respectively 3, 4
For COX-2 inhibition, Celecoxib and Parecoxib are preferred due to their low infant exposure and lack of adverse neonatal effects 3, 4